Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 2/20 | 0.62 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.62 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | LSS | P48449 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16150229 | 1.00 | SLC22A1 (0.62) | SLC22A1SLC22A2DNM1HTTALDH1A1 | |
| SCHEMBL638660 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 | |
| SCHEMBL4197957 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 | |
| SCHEMBL508824 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 | |
| SCHEMBL11103002 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 | |
| SCHEMBL2012703 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 | |
| SCHEMBL3857937 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 | |
| SCHEMBL15762688 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 | |
| SCHEMBL3369707 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 | |
| SCHEMBL5299524 | 0.97 | DNM1 (0.67) | SLC22A1DNM1HTTALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12252632-B2 | Chemical-mechanical polishing composition, rinse composition, chemical- mechanical polishing method, and rinsing method | ENTEGRIS, INC. (US) | 2025-03-18 | — | — | US | claimed |
| US-20220372329-A1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION, RINSE COMPOSITION, CHEMICAL-MECHANICAL POLISHING METHOD, AND RINSING METHOD | ENTEGRIS, INC. | 2022-11-24 | — | — | US | claimed |
| EP-4678690-A1 | ALKALINE HYDROLYSIS OF POLYETHYLENE TEREPHTHALATE USING PHASE TRANSFER CATALYSIS | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin (IE) | 2026-01-14 | — | — | EP | disclosed |
| US-12252632-B2 | Chemical-mechanical polishing composition, rinse composition, chemical- mechanical polishing method, and rinsing method | ENTEGRIS, INC. (US) | 2025-03-18 | — | — | US | disclosed |
| CN-117946544-B | Graphene premix, coating composition, and coated article | 宣伟(南通)涂料有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-117946544-A | Graphene premix, coating composition, and coated article | 宣伟(南通)涂料有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-111849369-B | Surface protective film and optical member | 日东电工株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-113382860-B | Adhesive sheet and use thereof | 日东电工株式会社 | 2024-03-22 | — | — | CN | disclosed |
| EP-4288155-A1 | CROSSLINKABLE COATING COMPOSITIONS | Elementis Specialties, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| EP-3824893-B1 | CROSSLINKABLE COATING COMPOSITIONS FORMULATED WITH DORMANT CARBAMATE INITIATOR | ELEMENTIS SPECIALTIES INC (US) | 2023-11-01 | — | — | EP | disclosed |
| US-11801214-B2 | Crosslinkable coating compositions formulated with dormant carbamate initiator | ELEMENTIS SPECIALTIES, INC. (US) | 2023-10-31 | — | — | US | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
| EP-1199306-B1 | BIARYLUREA DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2005-12-07 | — | — | EP | disclosed |
| US-6958333-B1 | Biarylurea derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-10-25 | — | — | US | disclosed |
| EP-1557168-A2 | Biarylurea Derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-07-27 | — | — | EP | disclosed |
| EP-1199306-A1 | BIARYLUREA DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2002-04-24 | — | — | EP | disclosed |
| EP-0102760-B1 | SUSPENSION POLYMERISATION PROCESS | Ciba Specialty Chemicals Water Treatments Limited (GB) | 1988-06-22 | — | — | EP | disclosed |
| US-4506062-A | WATER-SOLUBLE IONIC PROMOTER IN A STABILIZER-CONTAINING WATER IN OIL EMULSION; PARTICLE CONTROL | ALLIED COLLOIDS LIMITED (GB) | 1985-03-19 | — | — | US | disclosed |
| EP-0102760-A2 | Suspension polymerisation process | Ciba Specialty Chemicals Water Treatments Limited (GB) | 1984-03-14 | — | — | EP | disclosed |
| EP-0028516-A2 | Method for preparing crystalline zeolite, zeolites prepared thereby, catalysts containing them and use of such catalysts | MOBIL OIL CORPORATION (US) | 1981-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11801214-B2 | Crosslinkable coating compositions formulated with dormant carbamate initiator | ETF1, CECR2, H1-2 | SLC22A1 1500/4885SLC22A2 1461/4885DNM1 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.